No brainer for BrainZ
Wednesday, 08 October, 2008
BrainZ Instruments [ASX: BZI] is to be acquired by the US-based Natus Medical for NZ$1.3 million [AUD$1.13 million].
Pending shareholder approval, Natus will acquire essentially every trading asset of BrainZ - including products, IP and brand – except the company's cash reserves.
If the arrangement goes ahead, Natus will assume a number of the company’s distribution and customer support obligations.
BrainZ has developed a bedside brain monitoring technology that assists in the detection of brain injury and seizure activity in neonates.
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
